THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Scientists who studied Vioxx deny ethics breach

By Stephen Smith
Globe Staff / February 23, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Scientists who conducted a pivotal study of the blockbuster painkiller Vioxx yesterday insisted that they violated no ethical obligations by failing to include in a medical journal report all information about heart problems suffered by patients in the clinical trial. (Full article: 875 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass